Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



MOTT DAVID M Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 15,873 shares @ $0
07/06/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 6,079 shares @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 MOTT DAVID M (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 25,510 shares @ $0
Granted 49,237 options to buy @ $3.92, valued at $193k
06/12/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 14,467 shares @ $0
Granted 18,355 options to buy @ $8.64, valued at $158.6k
04/05/2023 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,866 shares @ $0
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 1,000,439 options to buy @ $0
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.
Txns: Granted 8,500 options to buy @ $1.07, valued at $9.1k
05/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2022 4 MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 20,653 shares @ $1.15, valued at $23.8k
02/23/2022 4 MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.
Txns: Bought 50,398 shares @ $1.3, valued at $65.5k
Bought 65,817 shares @ $1.56, valued at $102.7k
Bought 35,257 shares @ $1.46, valued at $51.5k
02/17/2022 4 MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.
Txns: Bought 19,552 shares @ $1.2, valued at $23.5k
Bought 11,779 shares @ $1.2, valued at $14.1k
Bought 14,595 shares @ $1.17, valued at $17.1k
02/14/2022 4 MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.
Txns: Bought 8,753 shares @ $1.29, valued at $11.3k
Bought 14,573 shares @ $1.23, valued at $17.9k
Bought 8,500 shares @ $1.18, valued at $10k
01/05/2022 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 18,518 options to buy @ $6.44, valued at $119.3k
01/04/2022 4 MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 9,500 shares @ $2.5, valued at $23.8k
10/01/2021 4 MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 4,640 shares @ $5.12, valued at $23.8k
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 579,494 options to buy @ $0
07/01/2021 4 MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 2,858 shares @ $8.31, valued at $23.7k
06/30/2021 4 MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.
Txns: Granted 7,728 options to buy @ $8.12, valued at $62.8k
06/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.
Txns: Granted 8,060 shares @ $0
Granted 40,559 options to buy @ $8.53, valued at $346k
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.
Txns: Granted 4,528 options to buy @ $21.09, valued at $95.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy